MarketBeat
09 Aug 2026, 23:06 UTC · 12w ago
Extendicare Q2 Earnings Call Highlights
Impact · against what's priced in
Extendicare's Q2 results show strong inorganic growth and improved financing, but the stock faces a transition from aggressive acquisition to integration. While acquisitions are exceeding underwriting targets, home health margins are under pressure due to labor inflation and a lack of rate increases in Ontario.
- EXE+0.40
No priced-in read yet
- In context
Revenue and adjusted EBITDA grew by 59.4% and 71% respectively, driven by acquisitions that are exceeding underwritten EBITDA levels. While debt costs were lowered via new senior notes, home health margins declined 60 bps to 12.9% due to labor inflation and missing rate increases.
Read from the article alone
